Navigation Links
The Lancet Publishes Vasogen's ACCLAIM Results
Date:1/18/2008

e destructive inflammatory process associated with the development and progression of cardiovascular and neurodegenerative disorders. The Company's lead product, the Celacade(TM) System, is designed to activate the immune response to apoptosis - an important physiological process that regulates inflammation. Celacade has received European regulatory approval under the CE Mark for chronic heart failure and is being marketed in the EU by Grupo Ferrer Internacional, S.A. Celacade is also in late-stage clinical development for the treatment of chronic heart failure in the United States. Vasogen is also developing a new class of drugs for the treatment of certain neuro-inflammatory disorders. VP025 is the lead candidate from this new class of drugs.

Certain statements contained in this press release, or elsewhere in our public documents constitute "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and/or "forward-looking information" under the Securities Act (Ontario). These statements may include, without limitation, plans to advance the development of Celacade(TM) or VP025, plans to fund our current activities, statements concerning our partnering activities, health regulatory submissions, strategy, future operations, future financial position, future revenues and projected costs. In some cases, you can identify forward-looking statements by terminology such as "may", "will", "should", "expects", "plans", "anticipates", "believes", "estimated", "predicts", "potential", "continue", "intends", "could", or the negative of such terms or other comparable terminology. We made a number of assumptions in the preparation of these forward-looking statements, including assumptions about the nature, size, and accessibility of the market for Celacade in the treatment of chronic heart failure, particularly in Europe, the regulatory approval process leading to commercialization and the availability of capital o
'/>"/>

SOURCE Vasogen Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R)
2. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
3. Consortium publishes Phase II map of human genetic variation
4. Vasogen Provides an Update on ACCLAIM-II Preparations
5. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
8. CNS Response Announces Fiscal Third Quarter 2007 Results
9. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
10. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... Algeta ASA (OSE: ALGETA), the,cancer therapeutics company, ... the,US, the Tulane Cancer Center, New Orleans, ... clinical study of Alpharadin in men with,castration-resistant ... has metastasized to the skeleton. , ... SYMptomatic Prostate CAncer) study is a,double-blind, randomized, ...
(Date:12/11/2009)... 11, 2009 -- Esco announces the opening of a NEW 2nd ... a technical service, training and logistics center to support Esco,s growth ... Product Introductions (NPI) for temperature-controlled laboratory equipment. , ... ... of a NEW 2nd North American facility in Marietta, OH. The ...
(Date:12/10/2009)... The National Eye Institute (NEI), a division of the National ... Aciont Inc. to help fund its development of a non-invasive, ... , ... Salt Lake City, UT (PRWEB) ... division of the National Institutes of Health (NIH), awarded a ...
(Date:12/10/2009)... Brooks Instrument, a world-leading provider of advanced flow ... Bayda will join the company as Global Level ... lead Brooks Instrument’s efforts to enhance market penetration ... He is joining Brooks Instrument from Lafarge Corp, ... as Director of Marketing and Sales. Bayda will ...
Breaking Biology Technology:Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3
... (NYSE: CRY ),a biomaterials, medical device and tissue ... 2007 financial results will be,released on Thursday, February 21, ... webcast at 10:00 a.m. Eastern Time, February,21, 2008, to ... session,hosted by Steven G. Anderson, president and chief executive ...
... help doctors and clinicians identify best ... risk of heart disease, BIRMINGHAM, Ala., Jan. 31 ... point to the need for more,detailed cholesterol testing, including ... Atherotech, a cardio-diagnostic company that,has developed an expanded cholesterol ...
... Fourth Quarter Worldwide Net Revenue Increased 10% to $5.8 Billion, and Reported Diluted Earnings ... Items, Increased 18% to ... $0.78, - 2007 Full Year Worldwide Net Revenue Increased ... Diluted, Earnings per Share, Before Certain Significant Items, Increased 12% to ...
Other Biology Technology:CryoLife Announces Release Date and Teleconference Call Details for the Fourth Quarter and Year End 2007 Financial Results 2Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 2Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 3Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 2Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 3Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 4Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 5Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 6Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 7Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 8Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 9Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 10Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 11Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 12Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 13Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 14Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year 15
(Date:12/13/2009)... 10, 2009Researchers at The Scripps Research Institute have ... protein from an ancient family of enzymes can ... In addition to providing guidance for understanding other ... theoretical underpinning for the protein,s possible use for ... The research was published in the December 13, ...
(Date:12/11/2009)... increases, growers are being challenged to bring consistently ... bottom line, orchard owners are experimenting with new ... labor costs. , Hand thinning, a common practice ... is among the most labor-intensive of orchard practices, ... and, ultimately, prices paid by consumers. A research ...
(Date:12/11/2009)... green plants photosynthesize, absorb carbon dioxide and produce ... that photosynthesis has had on Earth. One of ... evolution of photosynthesis is Jeffrey Touchman, assistant professor ... , Oxygen, one of the by-products of photosynthesis ... (including algae and higher plants), transformed the Precambrian ...
Breaking Biology News(10 mins):Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3Horizontal string trimmer reduces labor costs, increases peach size 2'Extreme' genes shed light on origins of photosynthesis 2'Extreme' genes shed light on origins of photosynthesis 3Lumension Webinar Highlights How Organizations Can Protect Information and Comply with Data Handling Procedures 51423 1Lumension Webinar Highlights How Organizations Can Protect Information and Comply with Data Handling Procedures 51423 2Lumension Webinar Highlights How Organizations Can Protect Information and Comply with Data Handling Procedures 51423 3Top Newport Beach Based Plastic Surgery Practice Triples Its Revenue 3B Celebrates Two Year Anniversary 51421 1Top Newport Beach Based Plastic Surgery Practice Triples Its Revenue 3B Celebrates Two Year Anniversary 51421 2Omnetics 26apos 3B Multi Contact Nano Connectors Obtain Digital Transmission Rates Over 2 Gb sec 51419 1Omnetics 26apos 3B Multi Contact Nano Connectors Obtain Digital Transmission Rates Over 2 Gb sec 51419 2
... can lead to urinary tract infections in women, according ... that UTIs may be caused by ingesting food contaminated ... Gastroenteric Disease Center. Previously, this link was not established, ... University of California-Berkeley, found that E.coli strains isolated from ...
... in forests between Gabon and the Republic of Congo ... according to a study by the Wildlife Conservation Society ... edition of the journal Emerging Infectious Diseases, the study ... 2001 and 2003 produced positive results, and found direct ...
... research indicates that it may all come down to ... scientists who had previously identified a key gene essential ... shows that this gene's function appears to be evolutionarily ... Leslie Vosshall's laboratory had previously shown that of 62 ...
Other Biology News:Bacteria collection sheds light on urinary tract infections 2Study Links Ebola Outbreaks To Animal Carcasses 2Ancient olfaction protein is shared by many bugs, offering new pest control target 2
... Complete kit for stabilizing 400g of purified ... optimised for the stabilization of aqueous RNA ... methods such as guanidine, phenol/chloroform, silica, oligo ... StabMRT Kits contain all the necessary components ...
... template is designed to allow kanamycin/neomycin selection ... It combines a prokaryotic promoter (gb2) for ... with a eukaryotic promoter (PGK) for ... The prokaryotic promoter gb2 is a ...
... culture flask is designed for culturing organisms requiring ... can also be used in serum production. Triple ... maximal oxygen transfer to culture medium. Beaded neck ... plugs or No. 13 rubber stoppers. This flask ...
... 30 isolations. The kit provides a simple ... cells from normal c lture using annexin ... a Ca2+-dependent phospholipid binding protein with high ... Isolation Kit provides a simple and efficient ...
Biology Products: